CMPX · Company research
Compass Therapeutics, Inc. (CMPX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| NSSC,MS,EMBC,HRTG,BWA,MANH,CMPX | Stock Prices | Quote Comparison - Yahoo Finance - Yahoo! Finance Canada | NSSC,MS,EMBC,HRTG,BWA,MANH,CMPX | Stock Prices | Quote Comparison - Yahoo Finance Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 14, 2026 | neutral | 0 | 0.6 |
| Compass Therapeutics (CMPX) Stock Fair Value Falls After Tovecimig Regulatory Concerns - Yahoo Finance | Compass Therapeutics (CMPX) Stock Fair Value Falls After Tovecimig Regulatory Concerns Yahoo Finance | View source ↗ | Yahoo Finance | Oct 14, 2026 | neutral | 0 | 0.6 |
| CMPX Jan 2028 1.500 put (CMPX280121P00001500) Interactive Stock Chart - Yahoo! Finance Canada | CMPX Jan 2028 1.500 put (CMPX280121P00001500) Interactive Stock Chart Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 6, 2026 | neutral | 0 | 0.6 |
| CMPX Oct 2026 2.000 put (CMPX261016P00002000) Stock Historical Prices & Data - Yahoo! Finance Canada | CMPX Oct 2026 2.000 put (CMPX261016P00002000) Stock Historical Prices & Data Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 5, 2026 | neutral | 0 | 0.6 |
| Compass Therapeutics (NasdaqCM:CMPX) Stock Price - Simply Wall Street | Compass Therapeutics (NasdaqCM:CMPX) Stock Price Simply Wall Street | View source ↗ | Simply Wall Street | Oct 5, 2026 | neutral | 0 | 0.6 |
| At $0.92 a share, Compass Therapeutics (CMPX) accounting chief buys 20,000 shares. - Stock Titan | At $0.92 a share, Compass Therapeutics (CMPX) accounting chief buys 20,000 shares. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| $CMPX stock is down 13% today. Here's what we see in our data. - Quiver Quantitative | $CMPX stock is down 13% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 1, 2026 | neutral | 0 | 0.6 |
| $CMPX stock is down 13% today. Here's what we see in our data. - Quiver Quantitative | $CMPX stock is down 13% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 1, 2026 | neutral | 0 | 0.6 |
| After buying 2,500 shares, Compass Therapeutics (CMPX) accounting chief reports a 400,000-share position - Stock Titan | After buying 2,500 shares, Compass Therapeutics (CMPX) accounting chief reports a 400,000-share position Stock Titan | View source ↗ | Stock Titan | Sep 25, 2026 | neutral | 0 | 0.6 |
| Compass Therapeutics CAO Neil Lerner buys $2,849 in CMPX shares - Investing.com | Compass Therapeutics CAO Neil Lerner buys $2,849 in CMPX shares Investing.com | View source ↗ | Investing.com | Sep 25, 2026 | neutral | 0 | 0.6 |
| Compass Therapeutics stock downgraded at Wedbush (CMPX:NASDAQ) - Seeking Alpha | Compass Therapeutics stock downgraded at Wedbush (CMPX:NASDAQ) Seeking Alpha | View source ↗ | Seeking Alpha | Sep 23, 2026 | neutral | 0 | 0.6 |
| Compass Therapeutics’ FDA Setback Raises Concerns On Wall Street — H.C. Wainwright Calls Tovecimig Filing Strategy ‘Risky’ - TradingView | Compass Therapeutics’ FDA Setback Raises Concerns On Wall Street — H.C. Wainwright Calls Tovecimig Filing Strategy ‘Risky’ TradingView | View source ↗ | TradingView | Sep 23, 2026 | neutral | 0 | 0.6 |
| Compass Therapeutics: A Promising, But Shrinking, Window Of Opportunity (NASDAQ:CMPX) - Seeking Alpha | Compass Therapeutics: A Promising, But Shrinking, Window Of Opportunity (NASDAQ:CMPX) Seeking Alpha | View source ↗ | Seeking Alpha | Sep 23, 2026 | neutral | 0 | 0.6 |
| Why Did Compass Therapeutics Stock Plunge Today? - Compass Therapeutics (NASDAQ:CMPX) - Benzinga | Why Did Compass Therapeutics Stock Plunge Today? - Compass Therapeutics (NASDAQ:CMPX) Benzinga | View source ↗ | Benzinga | Sep 22, 2026 | neutral | 0 | 0.6 |
| CMPX Stock Slides As Traders Watch Volatile Support Zone - StocksToTrade | CMPX Stock Slides As Traders Watch Volatile Support Zone StocksToTrade | View source ↗ | StocksToTrade | Sep 22, 2026 | neutral | 0 | 0.6 |
| CMPX Stock Crashes To Over 2-Year Lows — Why FDA Wants Another Cancer Therapy Trial Before Key Marketing Filing - Yahoo Finance | CMPX Stock Crashes To Over 2-Year Lows — Why FDA Wants Another Cancer Therapy Trial Before Key Marketing Filing Yahoo Finance | View source ↗ | Yahoo Finance | Sep 22, 2026 | neutral | 0 | 0.6 |
| CMPX Forecast — Price Target — Prediction for 2027 - TradingView | CMPX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| CMPX Stock Has Retail Buzzing Ahead Of High-Stakes Cancer Drug Trial Update - Stocktwits | CMPX Stock Has Retail Buzzing Ahead Of High-Stakes Cancer Drug Trial Update Stocktwits | View source ↗ | Stocktwits | Apr 27, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.